Items without sitelinks
Showing below up to 50 results in range #641 to #690.
- ergosterol biosynthetic process (Q21915)
- ergostane steroid (Q21914)
- rickets (Q21912)
- homogeneous organ (Q21911)
- parathyroid (Q21910)
- parathyroid gland disease (Q21909)
- hypoparathyroidism (Q21908)
- vitamin D2 metabolic process (Q21907)
- 9,10-secoergostane steroid (Q21906)
- Radiostol (Q21905)
- Ergocalciferols (Q21904)
- vitamin D5 metabolic process (Q21902)
- secosteroid (Q21901)
- pyridoxal phosphatase activity (Q21898)
- pyridoxal 4-dehydrogenase activity (Q21897)
- pyridoxamine-oxaloacetate transaminase activity (Q21896)
- pyridoxal kinase activity (Q21895)
- 4-pyridoxolactonase activity (Q21894)
- 4-pyridoxate (Q21893)
- pyridoxal oxidase activity (Q21892)
- pyridoxal biosynthetic process (Q21891)
- pyridoxal metabolic process (Q21890)
- pyridoxal import across plasma membrane (Q21889)
- pyridoxal transmembrane transport (Q21888)
- pyridoxal transmembrane transporter activity (Q21887)
- pyridoxal transport (Q21886)
- pyridoxal binding (Q21885)
- nicotinamide mononucleotide transmembrane transporter activity (Q21882)
- nicotinamide mononucleotide transport (Q21881)
- nicotinamide mononucleotide transmembrane transport (Q21880)
- oxidoreductase activity, acting on diphenols and related substances as donors (Q21878)
- dihydronicotinamide riboside quinone reductase activity (Q21877)
- nicotinamide riboside transport (Q21876)
- nicotinamide riboside transmembrane transporter activity (Q21875)
- pyridine nucleoside biosynthetic process (Q21874)
- nicotinamide riboside biosynthetic process (Q21873)
- nicotinamide riboside metabolic process (Q21872)
- pyridine nucleoside metabolic process (Q21871)
- pyridine nucleoside catabolic process (Q21870)
- nicotinamide riboside catabolic process (Q21869)
- constitutional dyserythropoietic anemia (Q21865)
- neoplastic syndrome (Q21864)
- hematologic cancer (Q21863)
- soft tissue disorder (Q21862)
- connective and soft tissue neoplasms (Q21861)
- musculoskeletal neoplasm (Q21860)
- musculoskeletal system cancer (Q21859)
- connective tissue neoplasm (Q21858)
- rare neoplastic disease (Q21857)
- rare tumor (Q21856)